Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials April 7, 2022 Auto Bot Aduhelm (Drug), alzheimer's disease, Biogen Inc, Centers for Medicare and Medicaid Services, Clinical Trials, Food and Drug Administration, Health Insurance and Managed Care, Medicare 0 Officials cited data showing the new Alzheimer’s drug has serious safety risks and may not help patients.